Clay Capital
Investor profile
Venture capital
Clay Capital has backed 3 European tech companies across 3 funding rounds between 2024 and 2025, joining rounds totalling €93M. Most active in Healthtech and Software. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2024–2025
2 yrs
Total round €
€93M
sum of rounds joined
Deals by year
distinct rounds / yearClay Capital — deals by year — interactive chart.
Data table
| Clay Capital — deals by year | |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
Top sectors
by dealsClay Capital — top sectors — interactive chart.
Data table
| Clay Capital — top sectors | |
|---|---|
| Healthtech | 2 |
| Software | 1 |
Stages
by dealsClay Capital — stages — interactive chart.
Data table
| Clay Capital — stages | |
|---|---|
| Other | 2 |
| Series B | 1 |
Countries
by dealsClay Capital — countries — interactive chart.
Data table
| Clay Capital — countries | |
|---|---|
| France | 1 |
| Germany | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- AgFunder1
- Betagro Ventures1
- BOLD1
- DeepTech & Climate Fonds1
- Dr. Hans Riegel Holding (HRH)1
- Europe Investment Council fund1
- Evonik Venture Capital GmbH1
- Farvatn Venture1
- FoodLabs1
- Happiness Capital1
- ICOS Capital Management1
- Kadmos Capital1
- LIBERSET1
- PINC1
- Redalpine1
- REWE Group1
- Savantus Ventures1
- Simon Capital1
- SOSV1
- Synbioven1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Infinite Roots (Mushlabs) | Germany | 1 | €53M |
| Abolis Biotechnologies | France | 1 | €35M |
| Scindo | UK | 1 | €4.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Infinite Roots (Mushlabs) | Series B | €53M | 2024-01 |
| Abolis Biotechnologies | Other | €35M | 2024-09 |
| Scindo | Other | €4.5M | 2025-09 |